Heterologous Surface Display Reveals Conserved Complement Inhibition and Functional Diversification of Borrelia burgdorferi Elp Proteins
Nathan HilliD, Lara M. Matulina, Cameron MacIntyre, M. Amine HassaniiD, Sheila ThomasiD, Matteo Luban, Isabelle Ward, Amina Abdalla, John M. LeongiD, Brandon L. GarciaiD, Jacob E. LemieuxiD
Abstract
Lyme disease is a tick-borne spirochetosis with diverse clinical manifestations. Phenotypic variation among Borrelia burgdorferi strains correlates with variable manifestations of Lyme disease in humans; this diversity is attributed in part to variation in surface-exposed lipoproteins, which are targets of the human antibody response and contribute to tissue adhesion, immune evasion, and other host interactions. Many B. burgdorferi lipoproteins are encoded as multi-copy gene families including the OspE/F- like leader peptide (Elp) protein family. To characterize Elp allelic variants, we adapted the Pseudomonas syringae ice nucleation protein (INP) system to present B. burgdorferi lipoproteins on the surface of Escherichia coli. We identified interactions with classical complement proteins and mapped binding regions in the E. coli system. We validated interactions using recombinant proteins and B. burgdorferi surface display. By assessing potential interactions with extracellular matrix components, we identified a novel interaction between Elp proteins and perlecan, a component of mammalian basement membranes, and revealed the bifunctional nature of Elps. Our findings reveal that Elps have undergone functional diversification while maintaining classical complement inhibition mediated by potent and conserved C1s binding and demonstrate that E. coli surface display offers an efficient, cost-effective, and relatively high throughput approach to characterize B. burgdorferi lipoproteins.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- FWCI
- 0.80
- Field percentile
- top 38%
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Lipoproteome screening of the Lyme disease agent identifies novel inhibitors of antibody-mediated complement killing
M. J. Pereira, B. Wager, … J. M. Leong·bioRxiv·Sep 23, 2021
- Outer surface lipoproteins from the Lyme disease spirochete exploit the molecular switch mechanism of the complement protease C1s
R. J. Garrigues, S. Thomas, … B. L. Garcia·bioRxiv·Aug 17, 2022
- Erp and Rev adhesins of the Lyme disease spirochete's ubiquitous cp32 prophages assist the bacterium during vertebrate infection
B. Stevenson, C. A. Brissette·Infection and ImmunityPeer-reviewed·Mar 15, 2023
- The dual activity of BBK32: Implications for simultaneous inhibition of borrelial-specific antibody-dependent complement activation and fibronectin binding
Alexandra D. Powell-Pierce, Charles E. Booth, … Jon T. Skare·PLoS PathogensPeer-reviewed·Jul 24, 2025
- Structural Elucidation of a Protective B cell Epitope on Outer Surface Protein C (OspC) of the Lyme disease spirochete, Borreliella burgdorferi
M. J. Rudolph, S. Davis, … N. J. Mantis·bioRxiv·Nov 28, 2022
- Structure of a human monoclonal antibody in complex with Outer surface protein C (OspC) of the Lyme disease spirochete, Borreliella burgdorferi
Michael J. Rudolph, Yang Chen, … Nicholas John Mantis·The Journal of ImmunologyPeer-reviewed·Sep 6, 2024